Gem Aromatics Ltd Q1 FY2027 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/w6tsa6iijpuw510tjollkar8.pdf

Key Takeaways


The Dahej Timing Mismatch

Aadit Shah: "Currently we're facing a timing mismatch, you know, where the cost of the new facility, the depreciation, interest, manpower cost, they are all, you know, kicked in to the current financials due to the standby capacity which has already kicked in. But however, the revenue from the higher margin product mix which is yet to come from our Krystal unit has not come in yet in our current financials."

Clove Supply Disruption

Yash Parekh: "So, once a clove tree is out, it doesn't take up to 10 years, but may take a little bit shorter time depending on the weather conditions about 2 years to 3 years because we are effectively getting it out from the leaves, right?"

New Product Verticals

Safranal / Citral derivatives

Cooling agents (Gemcool 3, 5, 23)

Phenol derivatives

Multipurpose plant

Yash Parekh: "And for cooling agents, for example, we've already been approved by the world's two largest companies who are consuming that product."

Demand Environment

Yash Parekh: "The demand remains as strong and back to normal levels."

Brazil Subsidiary & Geographic Expansion


Working Capital & Margins

Aadit Shah: "See, the -- we don't want to comment on that as of yet. We'll just -- you know, as the year goes by, we'll be in a better place to, you know, guide on both the revenue and the margins for FY '27."

Guidance & Commitments

CommitmentSpecificsTimeline
Safranal revenueContribution expected towards end of Q2, more meaningful from Q3End of Q2 FY27 / Q3 FY27
Cooling agents revenueMeaningful contribution expectedQ3 FY27
Phenol trial productionCommence towards end of Q2, followed by approvalsEnd of Q2 FY27
Phenol commercial productionTargeted during Q3, subject to approvals and quality processesQ3 FY27
Phenol meaningful revenueExpected in export marketQ4 FY27
Eugenol ramp-upFairly close to planned numbersBy year-end FY27
FY28 guidanceStronger guidance to be givenTowards end of calendar year
FY27 guidanceExplicitly declined to guide on revenue and marginsNo timeline given

Key Metrics

MetricQ1 FY27
Revenue from operations, standalone₹83 cr, up from ₹76 cr in Q1 FY26
Revenue from operations, consolidated₹99 cr, up from ₹88 cr in Q1 FY26
Gross margin, standalone17.7%, gross profit of ₹14.7 cr
Gross margin, consolidated16.7%, gross profit of ₹16.5 cr
EBITDA margin, standalone10.3%, EBITDA of ₹8.5 cr
EBITDA margin, consolidated3.3%, EBITDA of ₹3.3 cr
PAT, standalone₹7.3 cr
PAT, consolidatedLoss of ₹7.9 cr
Cash PAT, standalone₹8.9 cr
Cash PAT, consolidated₹1.3 cr
Depreciation, consolidated₹9.1 cr, higher following capitalization of substantial portion of Dahej facility
Total plant capex, Dahej~₹270 cr, of which nearly ₹265 cr incurred and substantially capitalized
Krystal revenue share outlookMore than 50% of overall revenue through FY28
Cooling agents capacity utilization~25% on 500-ton capacity expected this year, per analyst suggestion with management indicating "fairly close to those numbers"
Madagascar port shutdown~30 days due to cyclone and flooding, impacting clove raw material availability